(De)phosphorylation agents influence 5 alpha-reduction of testosterone in human prostate

J M Le Goff1, P M Martin, J P Raynaud

  • 1Laboratoire de Cancérologie, Faculté de Médecine Nord, CNRS UA 1175, Marseille, France.

Endocrinology
|September 1, 1988
PubMed

Insights

The study found that 5 alpha-reductase activity in human prostate tissue is energy-dependent. Enzyme activity, crucial for dihydrotestosterone (DHT) production, is influenced by ATP and phosphorylation.

Area of Science:

  • Biochemistry
  • Urology
  • Endocrinology

Background:

  • 5 alpha-reductase is a key enzyme in androgen metabolism.
  • Dihydrotestosterone (DHT) plays a critical role in prostate physiology and pathology.
  • Benign prostatic hyperplasia (BPH) involves alterations in prostatic enzyme activity.

Purpose of the Study:

  • To investigate the influence of energy metabolism on 5 alpha-reductase kinetics.
  • To explore the role of adenosine triphosphate (ATP) and 2,4-dinitrophenol (DNP) in regulating 5 alpha-reductase activity.
  • To examine the relationship between 5 alpha-reductase activity and prostatic acid phosphatase (PAP) concentration.

Main Methods:

  • Microsomal preparation from hyperplastic human prostates.
  • Enzyme kinetic assays measuring 5 alpha-reductase activity.
  • Dose-response studies with ATP and DNP.
  • Correlation analysis with prostatic acid phosphatase (PAP) levels.

Main Results:

  • 2,4-dinitrophenol (DNP) inhibited 5 alpha-reductase activity in a dose-dependent manner.
  • Adenosine triphosphate (ATP) increased 5 alpha-reductase activity dose-dependently.
  • A significant inverse correlation was observed between 5 alpha-reductase activity and PAP concentration within the same prostate sample.

Conclusions:

  • Prostate 5 alpha-reductase activity and subsequent DHT production are likely energy-dependent processes.
  • Enzyme activity may involve a phosphorylation step, suggesting a regulatory mechanism.
  • These findings have implications for understanding BPH pathogenesis and potential therapeutic targets.

Related Concept Videos

Phosphorylation01:02

Phosphorylation

The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers01:22

Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers

α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Testosterone: Functions and Regulation01:26

Testosterone: Functions and Regulation

The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...